Proposed modification of the Eighth Edition of the AJCC Staging System for Intrahepatic Cholangiocarcinoma

Detalhes bibliográficos
Autor(a) principal: Zhang, XF
Data de Publicação: 2021
Outros Autores: Xue, F, He, J, Alexandrescu, S, Marques, HP, Aldrighetti, L, Maithel, SK, Pulitano, C, Bauer, TW, Shen, F, Poultsides, GA, Soubrane, O, Martel, G, Koerkamp, BG, Itaru, E, Lv, Y, Pawlik, TM
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.17/4287
Resumo: Background: To improve the prognostic accuracy of the 8th edition of the American Joint Committee on Cancer (AJCC) staging system for intrahepatic cholangiocarcinoma (ICC) with establishment and validation of a modified TNM (mTNM) staging system. Methods: Data on patients who underwent curative-intent resection for ICC was collected from 15 high-volume centers worldwide (n = 643). An external validation dataset was obtained from the SEER registry (n = 797). The mTNM staging system was proposed by redefining T categories, and incorporating the recently proposed N status as N0 (no lymph node metastasis [LNM]), N1 (1-2 LNM) and N2 (≥3 LNM). Results: The 8th AJCC TNM staging system failed to stratify overall survival (OS) of stage II versus IIIA, stage IIIB versus IV, as well as overall stage III versus IV among all patients from the two databases, as well as stage I versus II, and stage III versus III among patients who had ≥6 LNs examined. There was a monotonic decrement in survival based on the proposed mTNM staging classification among patients derived from both the multi-institutional (Median OS, stage I 69.8 vs. II 37.1 vs. III 18.9 vs. IV 16.4 months, all p < 0.05), and SEER (Median OS, stage I 87.0 vs. II 29.3 vs. III 17.7 vs. IV 14.2 months, all p < 0.05) datasets, which was also verified among patients who had ≥6 lymph node harvested from both databases. Conclusion: The modified TNM staging system for ICC using the new T and N definitions provided an improved means to stratify patients relative to long-term OS versus the 8th AJCC staging.
id RCAP_056b7318dee0dd71dc8d1c311c0cf8aa
oai_identifier_str oai:repositorio.chlc.min-saude.pt:10400.17/4287
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Proposed modification of the Eighth Edition of the AJCC Staging System for Intrahepatic CholangiocarcinomaIntrahepatic cholangiocarcinomaHCC CIRBackground: To improve the prognostic accuracy of the 8th edition of the American Joint Committee on Cancer (AJCC) staging system for intrahepatic cholangiocarcinoma (ICC) with establishment and validation of a modified TNM (mTNM) staging system. Methods: Data on patients who underwent curative-intent resection for ICC was collected from 15 high-volume centers worldwide (n = 643). An external validation dataset was obtained from the SEER registry (n = 797). The mTNM staging system was proposed by redefining T categories, and incorporating the recently proposed N status as N0 (no lymph node metastasis [LNM]), N1 (1-2 LNM) and N2 (≥3 LNM). Results: The 8th AJCC TNM staging system failed to stratify overall survival (OS) of stage II versus IIIA, stage IIIB versus IV, as well as overall stage III versus IV among all patients from the two databases, as well as stage I versus II, and stage III versus III among patients who had ≥6 LNs examined. There was a monotonic decrement in survival based on the proposed mTNM staging classification among patients derived from both the multi-institutional (Median OS, stage I 69.8 vs. II 37.1 vs. III 18.9 vs. IV 16.4 months, all p < 0.05), and SEER (Median OS, stage I 87.0 vs. II 29.3 vs. III 17.7 vs. IV 14.2 months, all p < 0.05) datasets, which was also verified among patients who had ≥6 lymph node harvested from both databases. Conclusion: The modified TNM staging system for ICC using the new T and N definitions provided an improved means to stratify patients relative to long-term OS versus the 8th AJCC staging.ElsevierRepositório do Centro Hospitalar Universitário de Lisboa Central, EPEZhang, XFXue, FHe, JAlexandrescu, SMarques, HPAldrighetti, LMaithel, SKPulitano, CBauer, TWShen, FPoultsides, GASoubrane, OMartel, GKoerkamp, BGItaru, ELv, YPawlik, TM2022-11-17T15:20:16Z20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/4287engHPB (Oxford) . 2021 Sep;23(9):1456-1466.10.1016/j.hpb.2021.02.009info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:46:08Zoai:repositorio.chlc.min-saude.pt:10400.17/4287Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:21:36.897755Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Proposed modification of the Eighth Edition of the AJCC Staging System for Intrahepatic Cholangiocarcinoma
title Proposed modification of the Eighth Edition of the AJCC Staging System for Intrahepatic Cholangiocarcinoma
spellingShingle Proposed modification of the Eighth Edition of the AJCC Staging System for Intrahepatic Cholangiocarcinoma
Zhang, XF
Intrahepatic cholangiocarcinoma
HCC CIR
title_short Proposed modification of the Eighth Edition of the AJCC Staging System for Intrahepatic Cholangiocarcinoma
title_full Proposed modification of the Eighth Edition of the AJCC Staging System for Intrahepatic Cholangiocarcinoma
title_fullStr Proposed modification of the Eighth Edition of the AJCC Staging System for Intrahepatic Cholangiocarcinoma
title_full_unstemmed Proposed modification of the Eighth Edition of the AJCC Staging System for Intrahepatic Cholangiocarcinoma
title_sort Proposed modification of the Eighth Edition of the AJCC Staging System for Intrahepatic Cholangiocarcinoma
author Zhang, XF
author_facet Zhang, XF
Xue, F
He, J
Alexandrescu, S
Marques, HP
Aldrighetti, L
Maithel, SK
Pulitano, C
Bauer, TW
Shen, F
Poultsides, GA
Soubrane, O
Martel, G
Koerkamp, BG
Itaru, E
Lv, Y
Pawlik, TM
author_role author
author2 Xue, F
He, J
Alexandrescu, S
Marques, HP
Aldrighetti, L
Maithel, SK
Pulitano, C
Bauer, TW
Shen, F
Poultsides, GA
Soubrane, O
Martel, G
Koerkamp, BG
Itaru, E
Lv, Y
Pawlik, TM
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE
dc.contributor.author.fl_str_mv Zhang, XF
Xue, F
He, J
Alexandrescu, S
Marques, HP
Aldrighetti, L
Maithel, SK
Pulitano, C
Bauer, TW
Shen, F
Poultsides, GA
Soubrane, O
Martel, G
Koerkamp, BG
Itaru, E
Lv, Y
Pawlik, TM
dc.subject.por.fl_str_mv Intrahepatic cholangiocarcinoma
HCC CIR
topic Intrahepatic cholangiocarcinoma
HCC CIR
description Background: To improve the prognostic accuracy of the 8th edition of the American Joint Committee on Cancer (AJCC) staging system for intrahepatic cholangiocarcinoma (ICC) with establishment and validation of a modified TNM (mTNM) staging system. Methods: Data on patients who underwent curative-intent resection for ICC was collected from 15 high-volume centers worldwide (n = 643). An external validation dataset was obtained from the SEER registry (n = 797). The mTNM staging system was proposed by redefining T categories, and incorporating the recently proposed N status as N0 (no lymph node metastasis [LNM]), N1 (1-2 LNM) and N2 (≥3 LNM). Results: The 8th AJCC TNM staging system failed to stratify overall survival (OS) of stage II versus IIIA, stage IIIB versus IV, as well as overall stage III versus IV among all patients from the two databases, as well as stage I versus II, and stage III versus III among patients who had ≥6 LNs examined. There was a monotonic decrement in survival based on the proposed mTNM staging classification among patients derived from both the multi-institutional (Median OS, stage I 69.8 vs. II 37.1 vs. III 18.9 vs. IV 16.4 months, all p < 0.05), and SEER (Median OS, stage I 87.0 vs. II 29.3 vs. III 17.7 vs. IV 14.2 months, all p < 0.05) datasets, which was also verified among patients who had ≥6 lymph node harvested from both databases. Conclusion: The modified TNM staging system for ICC using the new T and N definitions provided an improved means to stratify patients relative to long-term OS versus the 8th AJCC staging.
publishDate 2021
dc.date.none.fl_str_mv 2021
2021-01-01T00:00:00Z
2022-11-17T15:20:16Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.17/4287
url http://hdl.handle.net/10400.17/4287
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv HPB (Oxford) . 2021 Sep;23(9):1456-1466.
10.1016/j.hpb.2021.02.009
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131310974828544